Study Design
SECONDARY
This was a prespecified secondary analysis of a double-blinded, parallel group randomized clinical parallel group trial conducted in Montreal, Quebec, Canada, from March 2016 to March 2019 and followed the Consolidated Standards of Reporting Trials (